Hantel A - Search Results

1

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Zalupski MM, Benedetti J, Balcerzak SP, Hutchins LF, Belt RJ, Hantel A, Goodwin JW. Zalupski MM, et al. Among authors: hantel a. Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435. Invest New Drugs. 1993. PMID: 8157477 Clinical Trial.

2

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trial.

Taylor SA, Benedetti J, Schuller D, Richman SP, Broun GO, Hantel A. Taylor SA, et al. Among authors: hantel a. Invest New Drugs. 1993 May-Aug;11(2-3):227-9. doi: 10.1007/BF00874161. Invest New Drugs. 1993. PMID: 8262737 Clinical Trial.

3

Phase II trial of piroxantrone in gastric carcinoma. A Southwest Oncology Group study.

Hantel A, Tangen C, Gluck WL, Macdonald JS. Hantel A, et al. Invest New Drugs. 1994;12(2):159-61. doi: 10.1007/BF00874449. Invest New Drugs. 1994. PMID: 7860236 Clinical Trial.

4

A phase II trial of piroxantrone in adenocarcinoma of the pancreas. A Southwest Oncology Group study.

Jenkins TR, Tangen C, Macdonald JS, Weiss G, Chapman R, Hantel A. Jenkins TR, et al. Among authors: hantel a. Invest New Drugs. 1993 Nov;11(4):329-31. doi: 10.1007/BF00874432. Invest New Drugs. 1993. PMID: 8157474 Clinical Trial.

5

A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918.

Malviya VK, Liu PY, Goldberg DA, Hantel A, O'Toole RV, Roach RW, Conrad ME, Alberts DS. Malviya VK, et al. Among authors: hantel a. Anticancer Drugs. 1996 Jul;7(5):527-30. doi: 10.1097/00001813-199607000-00006. Anticancer Drugs. 1996. PMID: 8862719 Clinical Trial.

6

A phase II trial of piroxantrone in disseminated malignant melanoma. A Southwest Oncology Group study.

Sosman JA, Flaherty LE, Liu PY, Fletcher W, Thompson JA, Hantel A, Sondak V. Sosman JA, et al. Among authors: hantel a. Invest New Drugs. 1995;13(1):83-7. doi: 10.1007/BF02614226. Invest New Drugs. 1995. PMID: 7499114 Clinical Trial.

7

Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.

Williamson SK, Crowley JJ, Livingston R, Hantel A, Doroshow JH. Williamson SK, et al. Among authors: hantel a. Invest New Drugs. 1992 Apr;10(1):29-30. doi: 10.1007/BF01275476. Invest New Drugs. 1992. PMID: 1318871 Clinical Trial. No abstract available.

8

Phase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.

Hantel A, Tangen CM, Macdonald JS, Richman SP, Pugh RP, Pollock T. Hantel A, et al. Invest New Drugs. 1994;12(2):155-7. doi: 10.1007/BF00874448. Invest New Drugs. 1994. PMID: 7860235 Clinical Trial.

9

Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.

Rowinsky EK, Grochow LB, Hantel A, Ettinger DS, Vito BL, Donehower RC. Rowinsky EK, et al. Among authors: hantel a. Invest New Drugs. 1989 Nov;7(4):317-25. doi: 10.1007/BF00173761. Invest New Drugs. 1989. PMID: 2599802

10

A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904.

Albain KS, Liu PY, Hantel A, Poplin EA, O'Toole RV, Wade JL 3rd, Maddox AM, Alberts DS. Albain KS, et al. Among authors: hantel a. Gynecol Oncol. 1995 Jun;57(3):407-11. doi: 10.1006/gyno.1995.1163. Gynecol Oncol. 1995. PMID: 7774846 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters